Drug General Information (ID: DDI6CGFLD4)
  Drug Name Zidovudine Drug Info Stavudine Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Anti-Hiv Agents Anti-Hiv Agents
  Structure

 Mechanism of Zidovudine-Stavudine Interaction (Severity Level: Moderate)
     Attenuated pharmacological effects (Unspecific) Click to Show/Hide Mechanism Graph
      Drug Name Zidovudine Stavudine
      Mechanism Intracellular phosphorylation inhibitor Prodrug activated by intracellular phosphorylation
      Key Mechanism Factor 1
Factor Name Pharmacodynamics
Factor Description Reduced pharmacological effects leading to insufficient efficacy and/or treatment failure.
      Mechanism Description
  • Attenuated pharmacological effects of  Zidovudine when combined with Stavudine 

Recommended Action
      Management The manufacturer recommends against concurrent use.

References
1 Product Information. Retrovir (zidovudine). Glaxo Wellcome, Research Triangle Park, NC.
2 Hoggard PG, Kewn S, Barry MG, Khoo SH, Back DJ. Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro. Antimicrob Agents Chemother. 1997 Jun;41(6):1231-6.
3 Havlir DV, Tierney C, Friedland GH, Pollard RB, Smeaton L, Sommadossi JP, Fox L, Kessler H, Fife KH, Richman DD "In vivo antagonism with zidovudine plus stavudine combination therapy." J Infec Dis 182 (2000): 321-5